Lunit, a Korean medical artificial intelligence (AI) startup, said Wednesday it has secured preliminary approval from a New Zealand high court for the acquisition of an Oceania-based breast cancer solution firm, Volpara Health.
/PRNewswire/ Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced an outstanding.
/PRNewswire/ Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a three-year supply.
/PRNewswire/ Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its proposal to.
/PRNewswire/ Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, partners with NTT DATA Singapore to.